GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMDCTx001 is an investigational ...
German company Complement Therapeutics, which has a research laboratory at Stevenage Bioscience Catalyst, reports that the ...
A team of NASA researchers is developing new types of optical masks that could help enable the many orders of magnitude of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results